This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1931 and headquartered in Northbrook, Illinois, The Allstate Corporation is the third-largest property-casualty (P&C) insurer and the largest publicly-held personal lines carrier in the U.S. The company also provides a range of life insurance and investment products to its diverse customer base. It provides insurance products to approximately 16 million households through more than 12,000 exclusive agencies and financial specialists in the U.S. and Canada.
5 Low-Beta High-Yielding Stocks to Buy Amid Fed-Induced Volatility
by Nalak Das
We have narrowed our search to five low-beta stocks with a solid dividend yield. These are: TSN, INGR, ALL, LDOS, GBCI.
Top Analyst Reports for Walmart, S&P Global & TotalEnergies
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Walmart Inc. (WMT), S&P Global Inc. (SPGI) and TotalEnergies SE (TTE), as well as two micro-cap stocks Crown Crafts, Inc. (CRWS) and Friedman Industries, Inc. (FRD).
4 Insurance Stocks to Secure Your Investments in the New Year
by Tanuka De
Driven by their strength, insurers like ALL, UNM, KINS and KMPR have not only crushed the market this year but are expected to retain the bull run next year too.
RLI Rises 17.9% in 6 Months: Can the Stock Retain the Bull Run?
by Zacks Equity Research
RLI stock rallies on the back of a strong local branch office network, a focus on specialty insurance lines and an impressive record of underwriting profits.
Best Income Stocks to Buy for December 18th
by Zacks Equity Research
BBAR, TPR and ALL made it to the Zacks Rank #1 (Strong Buy) income stocks list on December 18, 2024.
New Strong Buy Stocks for December 18th
by Zacks Equity Research
LTM, OMCL, DXPE, ALL and CRS have been added to the Zacks Rank #1 (Strong Buy) List on December 18, 2024.
PLMR Stock Surges 102.1% YTD: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Palomar Holdings stock gains from the strength of new business generated, strong retention rates, risk transfer strategy and solid capital position.
KNSL Stock Rallies 49.9% YTD: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Kinsale Capital stock rallies on the back of its focus on the excess and supply market, prudent underwriting, solid growth projections and effective capital deployment.
Allstate (ALL) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Allstate (ALL) reachead $195.02 at the closing of the latest trading day, reflecting a -0.63% change compared to its last close.
PGR's November Earnings Improve: Should You Buy or Hold the Stock?
by Tanuka De
Progressive stock seems well-poised on improving premiums, steady policy life expectancy, investment in technology and a solid capital position.
CINF Stock Rises 47.1% YTD: A Signal for Investors to Hold Tight?
by Zacks Equity Research
Cincinnati Financial stock rallies on the back of a higher level of insured exposure, an agent-focused business model, consistent cash flow and effective capital deployment.
Are Finance Stocks Lagging Credicorp (BAP) This Year?
by Zacks Equity Research
Here is how Credicorp (BAP) and Allstate (ALL) have performed compared to their sector so far this year.
Wall Street Analysts See Allstate (ALL) as a Buy: Should You Invest?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Allstate (ALL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ROOT Stock Skyrockets 627% YTD: Time to Buy Despite Premium Valuation?
by Tanuka De
Despite its expensive valuation, given its focus on driving growth, its price appreciation and its VGM Score of B, you can bet on ROOT stock.
Allstate (ALL) Stock Moves -0.52%: What You Should Know
by Zacks Equity Research
Allstate (ALL) concluded the recent trading session at $192.30, signifying a -0.52% move from its prior day's close.
TRV Stock Trading at a Premium to the Industry: Will You Still Buy It?
by Tanuka De
Despite its premium valuation, Travelers remains one of investors' favorites for addition to their portfolio.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ALL or KNSL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ALL vs. KNSL: Which Stock Is the Better Value Option?
4 Growth Stocks From P&C Insurance Space to Enhance Your Portfolio
by Sushmita Sarker
Given the prospects of the Property and Casualty Insurance industry, ALL, TRV, ROOT and MCY have the potential to generate better returns than other player.
Is Allstate (ALL) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Is Allstate (ALL) Up 11.6% Since Last Earnings Report?
by Zacks Equity Research
Allstate (ALL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Allstate (ALL) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Allstate (ALL) and Credicorp (BAP) have performed compared to their sector so far this year.
Is It Worth Investing in Allstate (ALL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Allstate (ALL) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Chubb Rallies 29% YTD but Lags Industry: How to Play the Stock
by Tanuka De
Investors who already hold CB stock should retain it, as this insurance behemoth is unlikely to disappoint. New investors can wait for a better entry point.
Allstate (ALL) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Allstate (ALL) have what it takes to be a top stock pick for momentum investors? Let's find out.